Figure 3

Experimental optimization of the automated photo(radio)synthesis of labeled protein. (a) Chemical structures of RhodB-PEG3-ArN3 and various DFO-PEG3-ArN3 compounds used in model reactions. (b) Photoactivation kinetics indicating the change in DFO-PEG3-ArN3 concentration over time measured by peak integration of HPLC chromatograms. (c) A plot of the radiochemical conversion (RCC) versus pH for the synthesis of 68GaDFO-PEG3-azepin-HSA. (d) Radio-ITLC traces (DTPA eluent) of neutralized 89Zr-oxalate before (black) and immediately after (blue) the addition of the photoactivatable DFO-PEG3-ArN3 chelate indicating rapid complexation. (e) Data on the experimental radiochemical conversion (RCC/%) or photochemical conversion yields (PCY/%) versus protein concentration for model reactions between HSA and RhodB-PEG3-ArN3 (pink), pre-labeled 68GaDFO-PEG3-ArN3 (blue), and simultaneous photoradiolabeling with 89Zr-oxalate plus DFO-PEG3-ArN3 (black). (f) Representative SEC-HPLC chromatograms of HSA (orange), purified RhodB-PEG3-azepin-HSA (pink) produced by full automation, and crude reaction mixtures (pre-purification) showing the light-induced formation of 68GaDFO-PEG3-azepin-HSA (blue) and 89ZrDFO-PEG3-azepin-HSA (black) at [HSA] = 15.9 mg mL-1.